Closed
SectorHealthcare
58.19 -6.75
24h
Min
57.47
Max
62.01
Income | 125M 159M |
---|---|
Sales | 191M 658M |
P/E Sector Avg | 27.274 63.778 |
EPS | 1.9 |
Profit margin | 24.156 |
Employees | 1,372 |
EBITDA | 138M 187M |
Recommendations | Strong Buy |
---|---|
12 Months Forecast | +164.8% upside |
Next Earnings | 30 kwi 2025 |
---|
Market Cap | -3.8B 6.8B |
---|---|
Previous open | 64.94 |
Previous close | 58.19 |
By Acuity
50%
50%
180 / 386 Ranking in Healthcare
By Trading Central
Confidence
Weak Bearish Evidence
Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.
Price change
By TipRanks
12 Months Forecast
Average 165.42 USD 164.8%
High 215 USD
Low 75 USD
Based on 20 Wall Street analysts offering 12 month price targets forSarepta Therapeutics Inc - Dist in the last 3 months.
By Acuity
News Sentiment
Neutral
Volatility
Below average
News Volume (RCV)
Below average
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$